After sweeping 70% of the order quantity the day before
540,000 weeks after opening the next day
In the securities industry, “Typical method
Stick to a professional speculator and reap huge profits”
Early in the market 10% up -1.4% close
viewer
SK Bioscience (302440)Lost the expectation of a’competitive ant’ and failed in the’tasangsang (two days in a row after listing)’. However, on the first day of listing, the so-called’Sangta Team’ reappeared, earning huge sums by taking the upper limit and selling it the next day. On the first day of listing, the so-called’Kyobo Team’, who took over 70% of the purchase volume through the Kyobo Securities window, sold most of the volume as soon as it opened on the 19th and earned 7 billion won in one day. The industry is raising suspicion that there is a professional speculative force aiming only at IPO.
SK Bioscience closed the market at 166,000 won, down 1.41% from the previous day on the 19th. It rose by more than 10% at the beginning of the market, and then gradually narrowed down as a large amount of profit-taking sales from Kyobo Securities and others fell, and eventually turned to a downtrend at the end.
On this day, at the Kyobo Securities window, the volume of goods poured out immediately after the opening, and a sell order of 480,000 shares was signed in 10 minutes. Sell orders continued, and a total of 540,000 shares were recorded at around 9:30 am. Earlier, Kyobo Securities drew attention by making a buy trade that sweeps over 530,000 shares, which is 70% of the total transaction volume, on the first day of SK Bioscience’s KOSPI listing. In this situation, the stock market predicts that the’big-handed investor’ using Kyobo Securities would have enjoyed billions of won in a day by buying a large quantity of stock the day before and selling it the day before.
In fact, even if all 530,000 shares purchased by the investor were signed at the upper limit of 169,000 won, the money earned is expected to reach at least 7 billion won. On this day, SK Bioscience’s stock price showed extreme volatility, starting at 187,000 won right after the opening, soaring to 188,500 won, and falling to 172,500 won in 10 minutes. An official in the securities industry said, “If the investor has secured the stock through trading on the 18th, the average purchase price may be lower than 169,000 won.” In view of that, there is a possibility that the valuation margin will reach 8 billion to 9 billion won.”
The industry is raising suspicion that there is a professional speculative force behind this happening. It is said that the Kyobo team’s technique is the epitome of ‘catching up to the upper limit’ that was popular in the past. The term ‘depending’ means that stocks that have reached their upper limit on the day often maintain a certain increase in stock prices on the following day.After securing as much of the stocks as possible on the next day, as much as 10-20. It is a method of making a profit up to the% level and selling it back. However, it is also a risky investment method that suffers great damage if the stocks that have suffered fall without rising the next day. An official in the industry said, “In the past, when the stock cap was 15%, such investment was popular as stocks with the upper limit were often continuing the upward trend the next day. There were many cases, but it seems to be an investment method aimed at such a sentiment.”
The reason for the doubt that there will be a speculative force is that it is virtually impossible for a brokerage company to monopolize the purchase volume in this way. SK Bioscience, which recorded a’tasang’ the previous day, has high expectations that it will continue its uptrend the next day, so there is no one selling stocks, but only buying ones throughout the week. In this situation, the industry explains that in order to dominate 70% of the purchase volume, not only a huge amount of funds but also a trading ability called’Kwang Kle’ is essential. This is because orders that are enormous enough to wipe out the circulating volume must be placed at a faster rate than anyone else. In this case, other orders will not be allocated stock until the first order’s quantity has been digested.
In fact, this unique transaction, which was sold the next day after the purchase volume was monopolized through Kyobo Securities, took place twice last year. On the first day of listing of SK Biopharm, which had a record of ‘Tasangsang’ and Kakao Games’ ‘Tasangsang’, the Kyobo team took over 70% of the purchase volume.
/ Reporter Kim Kyung-mi [email protected]
< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >